BME
BlackRock Health Sciences TrustCompany with tickers: BME
CIK
1314966
CUSIP
09250W107
Shares Outstanding
12,924,103
Website
https://www.blackrock.com
13F Activity (30d)
33 filings
31 filers
Portfolio holdings reported by registered funds to the SEC on Form N-PORT — the individual securities a fund owns. Only mutual funds, ETFs and closed-end funds file N-PORT, so operating companies show no data.
BlackRock Health Sciences Trust
Reported 2026-03-31Net Assets
$532,558,903
Total Assets
$536,656,640
Holdings
159
Filed
2026-05-28
| Holding | CUSIP | Balance | Units | Value | % Net Assets | Category | Country |
|---|---|---|---|---|---|---|---|
| GOLDFINCH EQUITY WARRANTS | 000000000 | 21,784 | NS | $0 | 0.00% | DE | US |
| CONTRA FREQUENCY THERA | 358CVR025 | 28,060 | NS | $0 | 0.00% | — | US |
| SWIFT HEALTH SYSTEMS INC | 000000000 | 93 | NS | $206 | 0.00% | EC | US |
| EXO IMAGING INC | 000000000 | 1,017 | NS | $376 | 0.00% | EC | US |
| Gossamer Bio Inc | 38341P102 | 31,955 | NS | $10,497 | 0.00% | EC | US |
| CONTRA MIRATI THERAPEU | 604CVR027 | 15,747 | NS | $12,440 | 0.00% | — | US |
| CONTRA BLUEPRINT MEDIC | 096CVR048 | 15,552 | NS | $15,552 | 0.00% | — | US |
| AFFINIVAX INC | 000000000 | 6,331 | NS | $23,235 | 0.00% | EC | US |
| Autolus Therapeutics PLC | 05280R100 | 23,620 | NS | $32,596 | 0.01% | EC | GB |
| CONTRA ABIOMED INC | 003CVR016 | 14,359 | NS | $33,313 | 0.01% | — | US |
| KARTOS THERAPEUTICS INC | 000000000 | 34,186 | NS | $34,343 | 0.01% | EC | US |
| EXO IMAGING INC | 000000000 | 47,496 | NS | $35,147 | 0.01% | EC | US |
| TScan Therapeutics Inc | 89854M101 | 48,273 | NS | $48,756 | 0.01% | EC | US |
| GOLDFINCH BIO INC | 000000000 | 168,216 | NS | $50,465 | 0.01% | EC | US |
| Orchestra BioMed Holdings Inc | 68572M106 | 17,635 | NS | $74,949 | 0.01% | EC | US |
| Nyxoah SA | 000000000 | 29,659 | NS | $86,604 | 0.02% | EC | BE |
| 4D Molecular Therapeutics Inc | 35104E100 | 11,491 | NS | $106,981 | 0.02% | EC | US |
| CELLARITY INC | 000000000 | 44,167 | NS | $107,767 | 0.02% | EC | US |
| MoonLake Immunotherapeutics | 61559X104 | 5,908 | NS | $110,125 | 0.02% | EC | KY |
| Syndax Pharmaceuticals Inc | 87164F105 | 5,165 | NS | $120,654 | 0.02% | EC | US |
| Voyager Therapeutics Inc | 92915B106 | 31,420 | NS | $121,281 | 0.02% | EC | US |
| KARTOS THERAPEUTICS INC | 000000000 | 23,610 | NS | $134,105 | 0.03% | STIV | US |
| BRIDGEBIO ONCOLOGY THERAPEUTICS INC | 000000000 | 15,582 | NS | $139,459 | 0.03% | EC | US |
| Corvus Pharmaceuticals Inc | 221015100 | 9,689 | NS | $141,750 | 0.03% | EC | US |
| REGENXBIO Inc | 75901B107 | 18,415 | NS | $154,318 | 0.03% | EC | US |
| NUCLEIX LTD | 000000000 | 200 | NS | $158,504 | 0.03% | EC | US |
| Vor BioPharma Inc | 929033207 | 10,020 | NS | $178,757 | 0.03% | EC | US |
| Ocular Therapeutix Inc | 67576A100 | 22,645 | NS | $191,803 | 0.04% | EC | US |
| Quanta Dialysis Technologies Ltd | 000000000 | 4,243,029 | NS | $202,179 | 0.04% | EC | GB |
| EyePoint Inc | 30233G209 | 16,320 | NS | $210,365 | 0.04% | EC | US |
| WaVe Life Sciences Ltd | 000000000 | 30,090 | NS | $218,153 | 0.04% | EC | SG |
| NUCLEIX LTD | 000000000 | 367,395 | NS | $242,481 | 0.05% | EP | US |
| INSITRO INC | 000000000 | 30,616 | NS | $255,950 | 0.05% | EC | US |
| Allogene Therapeutics Inc | 019770106 | 105,465 | NS | $257,335 | 0.05% | EC | US |
| Biohaven Ltd | 000000000 | 30,469 | NS | $257,768 | 0.05% | EC | VG |
| Upstream Bio Inc | 91678A107 | 30,052 | NS | $270,468 | 0.05% | EC | US |
| Bicara Therapeutics Inc | 055477103 | 14,144 | NS | $281,324 | 0.05% | EC | US |
| PTC Therapeutics Inc | 69366J200 | 4,329 | NS | $294,935 | 0.06% | EC | US |
| GENESIS THERAPEUTICS INC | 000000000 | 57,170 | NS | $312,720 | 0.06% | EC | US |
| BioNTech SE | 09075V102 | 3,695 | NS | $328,412 | 0.06% | EC | DE |
| Zealand Pharma A/S | 000000000 | 7,187 | NS | $334,699 | 0.06% | EC | DK |
| CG oncology Inc | 156944100 | 5,095 | NS | $344,830 | 0.06% | EC | US |
| Beam Therapeutics Inc | 07373V105 | 14,611 | NS | $348,180 | 0.07% | EC | US |
| KalVista Pharmaceuticals Inc | 483497103 | 18,705 | NS | $376,532 | 0.07% | EC | US |
| Kymera Therapeutics Inc | 501575104 | 4,712 | NS | $392,462 | 0.07% | EC | US |
| LARONDE INC | 000000000 | 21,100 | NS | $407,652 | 0.08% | EC | US |
| Aktis Oncology Inc | 01021M104 | 23,229 | NS | $415,567 | 0.08% | EC | US |
| Denali Therapeutics Inc | 24823R105 | 22,218 | NS | $426,586 | 0.08% | EC | US |
| Alcon AG | 000000000 | 5,751 | NS | $433,338 | 0.08% | EC | CH |
| Dyne Therapeutics Inc | 26818M108 | 23,908 | NS | $433,452 | 0.08% | EC | US |
Showing 1–50 of 159 holdings